Clinical Trial Update: Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL) [Phase 2]

View source ↗

Summary

This is an interventional Phase 2 trial evaluating a pentostatin, cyclophosphamide, and rituximab regimen for indolent B-cell non-Hodgkin lymphoma, including Wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Chronic Lymphocytic Leukemia
• Waldenström Macroglobulinemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Pentostatin (pentostatin)
• Rituximab (rituximab)

Snippet

Sponsor: Heidelberg University | Conditions: Immunocytoma/Morbus Waldenström, B-Cell Non-Hodgkin's Lymphoma | Phase 2 | Status: UNKNOWN